| Literature DB >> 19583202 |
Francis M Mann1, Meimei Xu, Xiaoming Chen, D Bruce Fulton, David G Russell, Reuben J Peters.
Abstract
Mycobacterium tuberculosis remains a widespread and devastating human pathogen. Presented here is the characterization of an atypical class I diterpene cyclase from M. tuberculosis that catalyzes an unusual cyclization reaction in converting the known M. tuberculosis metabolite halimadienyl diphosphate to a further cyclized novel diterpene, which we have termed edaxadiene, as it directly inhibits maturation of the phagosomal compartment in which the bacterium is taken up during infection.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19583202 PMCID: PMC2787244 DOI: 10.1021/ja9019287
Source DB: PubMed Journal: J Am Chem Soc ISSN: 0002-7863 Impact factor: 15.419
Scheme 1Cyclization of 1 to 3 Catalyzed by Rv3378c/MtEDS and the Corresponding Biomimetic Cyclization of 2 to 3
Figure 1Effect of edaxadiene (3) on phagosomal maturation. Analysis of the kinetics of phagosome maturation determined by ratio fluorometric measurements of (a) intraphagosomal pH (carboxyfluorescein), (b) intraphagosomal proteolytic activity (DQ Green protease substrate), and (c) intraphagosomal β-galactosidase activity (C12-fluorescein galactopyranoside), following bead uptake (solid lines = edaxadiene; dashed lines = control).